ACE and hydrops fetalis: Cardiotoxicity from ICIs includes late CAEs, with a median onset of 304 days; 73.7% experienced LVSD, and 47.4% developed HF. Continuous cardiac monitoring beyond 90 days and management with beta-blockers, ACE inhibitors, and ivabradine are essential.